Literature DB >> 20559780

NADPH oxidase and cardiac failure.

Junya Kuroda1, Junichi Sadoshima.   

Abstract

Increases in oxidative stress in the heart play an important role in mediating hypertrophy, apoptosis, fibrosis, mitochondrial dysfunction, and the consequent development of heart failure. Although it has been widely believed that electron leakage from the mitochondrial electron transport chain is the primary source of oxidative stress in the failing heart, increasing lines of evidence suggest that enzymes which produce reactive oxygen species may also contribute to it. NADPH oxidases are transmembrane enzymes dedicated to producing superoxide (O(2)(-)) by transferring an electron from NAD(P)H to molecular oxygen. Nox4 is a major NADPH oxidase isoform expressed in the heart. Nox4 is localized primarily at mitochondria in cardiac myocytes, and upregulation of Nox4 hypertrophic stimuli enhances O(2)(-) production, apoptosis, and mitochondrial dysfunction, thereby playing an important role in mediating cardiac dysfunction. Since Nox4 could be a key molecule mediating oxidative stress and pathological hypertrophy, it may serve as an important target of heart failure treatment. In this review, the importance of NADPH oxidases as sources of increased oxidative stress in the failing heart and the role of Nox4 in mediating growth and death of cardiac myocytes are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559780      PMCID: PMC3257318          DOI: 10.1007/s12265-010-9184-8

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  63 in total

Review 1.  Molecular composition and regulation of the Nox family NAD(P)H oxidases.

Authors:  Hideki Sumimoto; Kei Miyano; Ryu Takeya
Journal:  Biochem Biophys Res Commun       Date:  2005-09-06       Impact factor: 3.575

2.  Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes.

Authors:  Tetsuro Ago; Junya Kuroda; Jayashree Pain; Cexiong Fu; Hong Li; Junichi Sadoshima
Journal:  Circ Res       Date:  2010-02-25       Impact factor: 17.367

3.  Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction.

Authors:  M F Hill; P K Singal
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

4.  Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II.

Authors:  K Nakamura; K Fushimi; H Kouchi; K Mihara; M Miyazaki; T Ohe; M Namba
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

5.  Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells.

Authors:  Yves Gorin; Jill M Ricono; Nam-Ho Kim; Basant Bhandari; Goutam Ghosh Choudhury; Hanna E Abboud
Journal:  Am J Physiol Renal Physiol       Date:  2003-08

6.  Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.

Authors:  Jonathan A Byrne; David J Grieve; Jennifer K Bendall; Jian-Mei Li; Christopher Gove; J David Lambeth; Alison C Cave; Ajay M Shah
Journal:  Circ Res       Date:  2003-10-09       Impact factor: 17.367

Review 7.  Reactive oxygen species and matrix remodeling in diabetic kidney.

Authors:  Hunjoo Ha; Hi Bahl Lee
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

8.  A mechanistic role for cardiac myocyte apoptosis in heart failure.

Authors:  Detlef Wencker; Madhulika Chandra; Khanh Nguyen; Wenfeng Miao; Stavros Garantziotis; Stephen M Factor; Jamshid Shirani; Robert C Armstrong; Richard N Kitsis
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.

Authors:  Ulf Landmesser; Sergey Dikalov; S Russ Price; Louise McCann; Tohru Fukai; Steven M Holland; William E Mitch; David G Harrison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

10.  Increased myocardial NADPH oxidase activity in human heart failure.

Authors:  Christophe Heymes; Jennifer K Bendall; Philippe Ratajczak; Alison C Cave; Jane-Lise Samuel; Gerd Hasenfuss; Ajay M Shah
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

View more
  24 in total

1.  β₂-Adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another 'radical' road to heart failure?

Authors:  Fabio Di Lisa; Nina Kaludercic; Nazareno Paolocci
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

2.  Angiotensin II and oxidative stress in the failing heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

3.  Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium.

Authors:  Vasanthi R Muthusamy; Sankaranarayanan Kannan; Kamal Sadhaasivam; Sellamuthu S Gounder; Christopher J Davidson; Christoph Boeheme; John R Hoidal; Li Wang; Namakkal Soorappan Rajasekaran
Journal:  Free Radic Biol Med       Date:  2011-10-20       Impact factor: 7.376

4.  Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.

Authors:  Annayya R Aroor; Chirag Mandavia; Jun Ren; James R Sowers; Lakshmi Pulakat
Journal:  Cardiorenal Med       Date:  2012-02-07       Impact factor: 2.041

Review 5.  Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies.

Authors:  Dimitris Tousoulis; Nikolaos Papageorgiou; Alexandros Briasoulis; Emmanouel Androulakis; Marietta Charakida; Eleftherios Tsiamis; Christodoulos Stefanadis
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 6.  Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states.

Authors:  M Usman Khan; Yaser Cheema; Atta U Shahbaz; Robert A Ahokas; Yao Sun; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  Pflugers Arch       Date:  2012-02-11       Impact factor: 3.657

7.  Vidarabine, an anti-herpes agent, prevents occlusal-disharmony-induced cardiac dysfunction in mice.

Authors:  Yoshio Hayakawa; Kenji Suita; Yoshiki Ohnuki; Yasumasa Mototani; Misao Ishikawa; Aiko Ito; Megumi Nariyama; Akinaka Morii; Kenichi Kiyomoto; Michinori Tsunoda; Ichiro Matsuo; Hiroshi Kawahara; Satoshi Okumura
Journal:  J Physiol Sci       Date:  2022-02-11       Impact factor: 2.781

8.  Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease.

Authors:  Olivier Muller; Argyrios Ntalianis; William Wijns; Leen Delrue; Karen Dierickx; Reto Auer; Nicolas Rodondi; Fabio Mangiacapra; Catalina Trana; Michalis Hamilos; Emmanuel Valentin; Bernard De Bruyne; Emanuele Barbato; Jozef Bartunek
Journal:  J Cardiovasc Transl Res       Date:  2013-05-14       Impact factor: 4.132

9.  ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress.

Authors:  Yawen Gao; Yan Xu; Songwen Hua; Shenghua Zhou; Kangkai Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  QSYQ Attenuates Oxidative Stress and Apoptosis Induced Heart Remodeling Rats through Different Subtypes of NADPH-Oxidase.

Authors:  Yong Wang; Chun Li; Yuli Ouyang; Tianjiao Shi; Xiaomin Yang; Junda Yu; Qi Qiu; Jing Han; Yan Wu; Binghua Tang; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.